LOLouise Margaret O'BRien

Louise Margaret O'BRien

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Louise Margaret O'BRien has a total of 168 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Obstructive Sleep Apnea in Children With Lennox‐Gastaut Syndrome: A Case Series

    by Gita Gupta, Louise M. O'BRien, Fauziya Hassan, Stephanie M. D. Rau, Arushi Gupta, Renée A Shellhaas

    Background: Lennox–Gastaut syndrome (LGS) is a highly refractory epilepsy syndrome associated with poor sleep. Abnormal sleep can lower seizure threshold, yet a treatable cause of disordered sleep, obstructive sleep apnea (OSA), is understudied in children with LGS. We assessed the frequency of objectively diagnosed OSA and concordance of screening questionnaires with polysomnography results. Methods: Caregivers of children (< 18 years) with LGS completed the Pediatric Sleep Questionnaire Sleep‐Related Breathing Disorders (PSQ‐SRBD) subscale and could opt to undergo overnight polysomnography. A positive polysomnogram was defined as an obstructive apnea–hypopnea index (OAHI) ≥ 1. PSQ‐SRBD scores were compared between children who did and did not undergo polysomnography. Results: Caregivers of 31 children with LGS completed the PSQ‐SRBD; however, only 26 responses were valid based on the scoring criteria. Twenty out of twenty six (77%) screened positive. Among completed polysomnograms, 6/10 (60%) were positive for OSA. PSQ‐SRBD scores did not differ between participants who opted in versus out of polysomnography. In the subset completing both the questionnaire and polysomnogram ( n = 9), results were concordant in 5/9; two children with negative PSQ‐SRBD had OSA on polysomnography. Conclusions: OSA appears highly prevalent in children with LGS, but a standard questionnaire missed OSA in a substantial minority. These findings support a low threshold for polysomnogram‐based OSA screening in children with LGS.

  • Open Access

    Feasibility of sleep assessment modalities in children with Lennox-Gastaut syndrome

    by Gita Gupta, Louise M. O’BRien, Fauziya Hassan, Jonathan Jun, Stephanie M.D. Rau, Arushi Gupta, Raayed Saeed, Renée A. Shellhaas


  • Preconception sleep, pregnancy loss, and adverse pregnancy outcomes among women with a history of pregnancy loss

    by Joshua R Freeman, Brian W Whitcomb, Elizabeth R Bertone-Johnson, Louise M O’bRien, Galit L Dunietz, Alexandra C Purdue-Smithe, Keewan Kim, Robert M Silver, Enrique F Schisterman, Sunni L Mumford

    STUDY QUESTION: Are preconception sleep characteristics associated with pregnancy loss and adverse pregnancy outcomes? SUMMARY ANSWER: Preconception sleep characteristics were not associated with pregnancy loss, but earlier sleep midpoints were associated with lower risk of adverse pregnancy outcomes, while social jetlag >1 h was associated with greater risk of a composite of adverse pregnancy outcomes. WHAT IS KNOWN ALREADY: Short sleep duration in mid-pregnancy has been associated with risk of second-trimester pregnancy loss, preterm birth (PTB), and hypertensive disorders of pregnancy (HDP). The relationships between preconception sleep and pregnancy loss, and adverse pregnancy outcomes have not been well characterized, despite plausible links. STUDY DESIGN, SIZE, DURATION: This was a secondary analysis of a randomized controlled trial conducted between 2006 and 2012 that prospectively followed 1228 women who were attempting to become pregnant after a history of pregnancy loss. Women were followed for ≤6 cycles while attempting pregnancy, and throughout pregnancy if they conceived. Over the follow-up, 140 women withdrew from the study. PARTICIPANTS/MATERIALS, SETTING, METHODS: This study evaluated baseline, self-reported preconception sleep duration, sleep latency, sleep midpoint, and social jetlag with risk of pregnancy loss and adverse pregnancy outcomes (e.g. PTB, HDP, and gestational diabetes (GDM)) among 1228 women with a history of pregnancy loss in the EAGeR trial. Pregnancy was documented by hCG tests; 797 women became pregnant over the follow-up. Pregnancy losses were defined as any loss after a positive hCG test; there were 188 pregnancy losses. PTB, HDP, and GDM cases were ascertained via medical record abstraction. PTB (n = 53), HDP (n = 62), and GDM (n = 22) were examined as a composite outcome (n = 118) and PTB and HDP were examined individually in exploratory analyses. GDM was not examined individually due to insufficient numbers. Log-Poisson models were used to estimate relative risks (RR) and 95% CIs for associations between preconception sleep characteristics, and pregnancy loss or adverse pregnancy outcomes with adjustment for age, BMI, lifestyle, and sociodemographic factors. Stabilized inverse probability weights were applied to address potential selection bias from loss to follow-up and from restricting to pregnancy. MAIN RESULTS AND THE ROLE OF CHANCE: Preconception sleep characteristics were not associated with risk of pregnancy loss. Preconception sleep duration and sleep latency were not associated with risk of the composite adverse pregnancy outcome. Early preconception sleep midpoints were associated with a lower risk of the composite adverse pregnancy outcome (first vs second tertile RR; 0.63, 95% CI: 0.40, 0.98) and preconception social jetlag was associated with a higher risk of the composite adverse pregnancy outcome (>1 vs ≤1 h RR; 1.65, 95% CI: 1.11, 2.44). LIMITATIONS, REASONS FOR CAUTION: Preconception sleep was restricted to baseline self-report, which may be non-differentially misclassified and may underestimate these associations. The EAGeR study did not measure sleep during pregnancy. There were few adverse pregnancy outcomes and thus limited power to evaluate individual outcomes; the findings could be due to chance. WIDER IMPLICATIONS OF THE FINDINGS: These findings suggest that preconception sleep is not associated with pregnancy loss, but preconception sleep timing may be relevant for risk of adverse pregnancy outcomes. Additional studies on preconception sleep and adverse pregnancy outcomes are needed given the potential impact of poor sleep on pregnancy outcomes. STUDY FUNDING/COMPETING INTEREST(S): Joshua R. Freeman and this work were supported by the Intramural Research Program Cancer Research Training Award, National Cancer Institute, National Institutes of Health (ZIA CP010197), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (Contract numbers: HHSN267200603423, HHSN267200603424, HHSN267200603426, HHSN275201300023I). Dr Silver received NIH funding through the listed contracts as site-PI for the original EAGeR trial at the University of Utah. Dr O’Brien reports receiving funding from the Star Legacy Foundation (paid to institution); an advisory board role at the Star Legacy Foundation; and receiving travel support from the Star Legacy Foundation. Dr Dunietz reports a role as Associate Editor at Human Reproduction and a role on the Journal Editorial Board of SLEEP. Dr Purdue-Smithe is an employee of Merck & Co. and has received stock compensation as an employee of Merck & Co. in the past 36 months. The work in this manuscript was completed before Dr Purdue-Smithe’s employment at Merck & Co. and is unrelated to Dr Purdue-Smithe’s work at the company. Dr Silver reports royalties or licenses from BJOG and UpToDate, Inc. in the past 36 months, receiving payment or honoraria for Grand Rounds in the past 36 months, and participating on a Data Safety Monitoring Board or Advisory Board for a National Institutes of Health-funded Apple Trial in the past 36 months. The other authors report there are no competing interests to declare. TRIAL REGISTRATION NUMBER: Clinicaltrials.gov NCT00467363


  • Sleep timing and duration in relation to blood leukocyte DNA methylation in adolescents: an epigenome-wide analysis

    by Erica C Jansen, Jennifer T Lee, Dana Dolinoy, Helen J Burgess, Ronald D Chervin, Karen E Peterson, Louise M O’bRien, Martha María Téllez-Rojo, Alejandra Cantoral, Libni Torres-Olascoaga, et al.

    Study Objectives: To investigate associations between adolescent sleep duration and timing, and blood leukocyte DNA methylation, one type of epigenetic modification that may respond to changes in sleep. Methods: Cross-sectional epigenome-wide analysis of DNA methylation was conducted to identify sleep-related CpG sites in 269 females and 233 males (14.4 ± 2.1 years on average) from the ELEMENT cohort study, in Mexico City. Sleep duration and midpoint on weekdays and weekends were assessed using 7-day wrist actigraphy (Actigraph GTX-BT), and DNA methylation in blood leukocytes was measured using the Illumina Infinium Methylation EPIC BeadChip. Linear regression was conducted to assess the relationship between sleep variables and DNA methylation at each array locus, adjusting for demographic confounders, batch effects, and cell types. Differentially methylated regions (DMRs) were assessed using ipDMR, and subsequent pathway analysis of relevant genes was conducted. Results: At false discovery rate-adjusted p-value (Q) < .05, there was one inverse site-specific association between sleep midpoint on weekends and cg04070324 (not annotated to a specific gene) among males only (Q = 0.02). However, DMR analysis in the full sample revealed 1875 total significant DMRs at Q < 0.05, and there was little overlap of DMRs associated with sleep duration versus midpoint. Sex-stratified analysis revealed more associations among males than females (e.g. 3284 DMRs compared to 1346). Based on pathway enrichment analysis, the male-specific pathways for sleep duration were related to DNA and metabolism, whereas for sleep midpoint they were related to developmental processes. Conclusions: Epigenome-wide analysis identified distinct associations with sleep duration and timing, especially among male adolescents.


  • Maternal early pregnancy body mass index and risk of insomnia in the offspring

    by Mia Q Zhu, Sven Cnattingius, Louise M O’bRien, Eduardo Villamor

    Study Objectives: To investigate the association between maternal early pregnancy body mass index (BMI) and risk of offspring insomnia. Methods: We conducted a nationwide cohort study among 3 281 803 singleton live births in Sweden born 1983–2015. Using national registries with prospectively recorded information, we followed participants for an insomnia diagnosis from 2 to up to 35 years of age. We compared insomnia risks by early pregnancy BMI categories using hazard ratios (HR) with 95% confidence intervals (CI) from adjusted Cox models. To assess unmeasured shared familial confounding, we conducted sibling-controlled analyses among 1 724 473 full siblings and studied the relation of maternal full sisters’ BMI and insomnia risk in 1 185 998 offspring. Results: There were 7154 insomnia diagnoses over a median follow-up age of 17.9 years. Compared with women with normal BMI, adjusted HR (95% CI) of offspring insomnia for early pregnancy BMI categories overweight, obesity class I, and obesity classes II or III were, respectively, 1.22 (1.14, 1.30), 1.60 (1.45, 1.77), and 2.11 (1.83, 2.45). Corresponding adjusted HR (95% CI) in sibling comparisons were, respectively, 1.32 (1.05, 1.65), 1.48 (1.03, 2.14), and 1.56 (0.91, 2.65). Associations with maternal sisters’ BMI were attenuated, suggesting a weak role for unmeasured shared factors. Other pregnancy, birth, and neonatal complications were associated with the risk of insomnia in offspring but did not substantially mediate the association. Conclusions: The dose–response relation between maternal overweight and obesity severity with offspring insomnia risk is not fully explained by shared familial factors.


  • Open Access

    Weight-neutral approach and later sleep midpoint in adolescents with “emerging polycystic ovary syndrome phenotype” as vehicles for sustainable weight loss

    by Josephine Z. Kasa-Vubu, Alexandra Waisanen, Julie Sturza, Vasantha Padmanabhan, Louise M. O’brien


  • Delayed Sleep Midpoint Across Pregnancy Is Associated with Excessive Gestational Weight Gain

    by Chia-Lun Yang, Jean M. Kerver, Kelly Hirko, Galit Levi Dunietz, Louise M. O'BRien, Erica C. Jansen

    Background:Changes in sleep patterns and body weight occur during pregnancy, yet it is unclear whether sleep patterns are related to gestational weight gain (GWG). This study examined the relations...


  • Open Access

    Sleep Disparities Across Pregnancy: A Michigan Cohort Study

    by Chia-Lun Yang, Erica C. Jansen, Galit Levi Dunietz, Kelly Hirko, Louise M. O'BRien, Jean M. Kerver

    Introduction: Poor sleep health during pregnancy is related to adverse pregnancy outcomes. This study aims to identify sociodemographic characteristics associated with sleep health during pregnancy and to examine how they relate to changes in sleep during pregnancy. Materials and Methods: Participants ( n = 458) were from the Michigan Archive for Research on Child Health, which is a prospective pregnancy cohort. Sociodemographic characteristics and self-reported sleep timing and quality were collected in phone interviews. This longitudinal study collected sleep parameters once during the early trimesters and once during the third trimester. Fall asleep and wake-up times were used to calculate sleep duration and sleep midpoint. Results: Compared to the third trimester, sleep duration was 12 minutes longer ( p = 0.02), fall asleep time was 21 minutes earlier ( p < 0.001), and the midpoint of sleep was 12 minutes earlier ( p = 0.01) in early trimesters. Shorter sleep duration was noted in younger women. Sleep midpoint was later in those who were younger, overweight, or obese, racial minorities, unmarried, and with lower educational levels or socioeconomic status, and who smoked before pregnancy after adjusting for covariates. After controlling for confounders, women who were not working for pay had higher likelihood of reduced sleep duration, and women who were unmarried were more likely to have a delayed sleep midpoint in the third trimester compared to the early trimesters. Conclusions: This study suggests that sleep parameters changed during pregnancy and sleep health differed by sociodemographic characteristics. Understanding sleep disparities could help with early detection of at-risk populations during prenatal care.


  • Open Access

    Racial/ethnic disparities in subjective sleep duration, sleep quality, and sleep disturbances during pregnancy: an ECHO study

    by Maristella Lucchini, Louise M O’bRien, Linda G Kahn, Patricia A Brennan, Kelly Glazer Baron, Emily A Knapp, Claudia Lugo-Candelas, Lauren Shuffrey, Galit Levi Dunietz, Yeyi Zhu, et al.

    In the United States, racial/ethnic minoritized groups experience worse sleep than non-Hispanic Whites (nHW), but less is known about pregnant people. This is a key consideration since poor sleep during pregnancy is common and associated with increased risk of adverse perinatal outcomes. This study reports the prevalence of subjective sleep measures in a multi-racial/ethnic pregnant population from the Environmental influences on Child Health Outcomes (ECHO) program. Participants’ self-reported race and ethnicity were grouped into: nHW, non-Hispanic Black/African American (nHB/AA), Hispanic, non-Hispanic Asian (nHA). Analyses examined trimester-specific (first (T1), second (T2), third (T3)) nocturnal sleep duration, quality, and disturbances (Pittsburgh Sleep Quality Index and ECHO maternal sleep health questionnaire). Linear or multinomial regressions estimated the associations between race/ethnicity and each sleep domain by trimester, controlling for body mass index and age, with nHW as reference group. We repeated analyses within maternal education strata. nHB/AA participants reported shorter sleep duration (T2: β = –0.55 [–0.80,–0.31]; T3: β = –0.65 [–0.99,–0.31]) and more sleep disturbances (T2: β = 1.92 [1.09,2.75]; T3: β = 1.41 [0.09,2.74]). Hispanic participants reported longer sleep duration (T1: β = 0.22 [0.00004,0.44]; T2: β = 0.61 [0.47,0.76]; T3: β = 0.46 [0.22,0.70]), better sleep quality (Reference group: Very good. Fairly good T1: OR = 0.48 [0.32,0.73], T2: OR = 0.36 [0.26,0.48], T3: OR = 0.31 [0.18,0.52]. Fairly bad T1: OR = 0.27 [0.16,0.44], T2: OR = 0.46 [0.31, 0.67], T3: OR = 0.31 [0.17,0.55]), and fewer sleep disturbances (T2: β = –0.5 [–1.0,–0.12]; T3: β = –1.21 [–2.07,–0.35]). Differences persisted within the high-SES subsample. Given the stark racial/ethnic disparities in perinatal outcomes and their associations with sleep health, further research is warranted to investigate the determinants of these disparities.